Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H. Umehara H, et al. Among authors: hibi t. Mod Rheumatol. 2012 Feb;22(1):21-30. doi: 10.1007/s10165-011-0571-z. Epub 2012 Jan 5. Mod Rheumatol. 2012. PMID: 22218969
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies.
Kobayashi T, Matsuoka K, Watanabe M, Hisamatsu T, Hirai F, Milata J, Li X, Morris N, Arora V, Ishizuka T, Matsuo K, Satoi Y, Milch C, Hibi T. Kobayashi T, et al. Among authors: hibi t. Intest Res. 2024 Apr;22(2):172-185. doi: 10.5217/ir.2023.00043. Epub 2024 Apr 25. Intest Res. 2024. PMID: 38720466 Free PMC article.
Effects of the COVID-19 pandemic on short-term postoperative outcomes for colorectal perforation: A nationwide study in Japan based on the National Clinical Database.
Ogawa S, Endo H, Yoshida M, Tsuru T, Itabashi M, Yamamoto H, Kakeji Y, Ueno H, Kitagawa Y, Hibi T, Taketomi A, Ikeda N, Mori M. Ogawa S, et al. Among authors: hibi t. Ann Gastroenterol Surg. 2023 Nov 23;8(3):450-463. doi: 10.1002/ags3.12758. eCollection 2024 May. Ann Gastroenterol Surg. 2023. PMID: 38707225 Free PMC article.
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
Schreiber S, Hunter Gibble T, Panaccione R, Rubin DT, Travis S, Hibi T, Potts Bleakman A, Panni T, Favia AD, Kayhan C, Atkinson C, Saxena S, Dubinsky MC. Schreiber S, et al. Among authors: hibi t. Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08434-5. Online ahead of print. Dig Dis Sci. 2024. PMID: 38700629
A novel scoring system to predict short-term mortality after living donor liver transplantation for acute liver failure.
Shimata K, Yoon YI, Hibi T, Morinaga J, Narayanan AK, Toshima T, Ito T, Akamatsu N, Kotera Y, Hong SK, Hasegawa Y, Umeda Y, Reddy MS, Ong AL, Sivaprasadan S, Varghese J, Sugawara Y, Chen CL, Suh KS, Ikegami T, Lee KW, Lee SG; Vanguard Multicenter Study of iLDLT (International Living Donor Liver Transplantation) group; Sudhindran S, Yoshizumi T, Hatano E, Okumura S, Hasegawa K, Egawa H, Obara H, Yasui K, Ogura Y, Jobara K, Nitta H, Katagiri H, Otsuka M, Kuboki S, Eguchi S, Hara T, Eguchi H, Sasaki K, Aoki T, Ohdan H, Ohira M, Takada Y, Ogawa K, Fukumoto T, Kuramitsu K, Saiura A, Ichida H, Hashimoto T, Marubashi S, Sato N, Ushigome H, Harada S, Soejima Y, Masuda Y, Shimada M, Saitou Y, Taketomi A, Goto R, Shimamura T, Mizuno S, Tanemura A, Endo I, Unno M, Miyagi S, Okamura Y, Aramaki O, Hakamada K, Ishido K, Kato Y, Takahara T, Takatsuki M, Ono S. Shimata K, et al. Among authors: hibi t. Am J Transplant. 2024 Apr 29:S1600-6135(24)00288-0. doi: 10.1016/j.ajt.2024.04.016. Online ahead of print. Am J Transplant. 2024. PMID: 38692411 Free article.
Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study.
Suzuki K, Sameshima Y, Yokoyama J, Terai S, Yoneyama H, Atreya R, Neurath MF, Hibi T, Asakura H. Suzuki K, et al. Among authors: hibi t. Inflamm Regen. 2024 Apr 25;44(1):22. doi: 10.1186/s41232-024-00332-7. Inflamm Regen. 2024. PMID: 38664814 Free PMC article.
1,237 results